Dr. Alison Moskowitz is an Associate Attending within the Lymphoma service at Memorial Sloan Kettering Cancer Center. She is a clinical investigator, dedicated to developing novel treatment approaches for patients with relapsed or refractory Hodgkin lymphoma and identifying factors predictive of response to therapy and overall outcomes. The aim of this work is to ultimately develop individualized therapy for patients with Hodgkin lymphoma that optimizes cure and limits long-term toxicity.